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SUMMARY 
Comparison of C.S. F. H. V. A and 5-HIAA levels ot 20 Schizophrenics and 9 non-schizophrenic 
controls revealed no statistically significant difference between HVA levels but the 5-HIAA levels were 
significantly less in Schizophrenics (p < 0.05) than in controls. The significance of these findings is discussed. 
Dopamine hypothesis of schizophrenia, 
according to which schizophrenia occurs 
due to functional overactivity of dopamine 
first given by Carlsson and Lindquist 
(1963), is the most accepted hypothesis 
today (Matthysse and Sugarman 1978). In 
spite of so many indirect evidences in fa-
vour of this hypothesis (Yaryura-Tobias et 
al 1979, Matthysse and Lipinski 1975, 
Snyder et al 1970, Matthysse and Kety 
1974, Siggins et al 1974, Bunney and Agha-
janian 1975, Randrup and Munkvad, 1974) 
there is no direct proof to support this 
hypothesis. Contrary to expections, major-
ity of the studies (Persson and Ross 1969, 
Bowers et al 1969, Rimon et al 1971, Post et 
al 1975) have shown no rise inC. S. F. HVA 
(which is the main metabolite of dopam-
ine) and the same is true of studies employ-
ing probenecid technique (Bowers 1974 c, 
Post et al 1975, Subrahmanyam 1975). 
While these studies have failed to show any 
significant change in HVA, at least three 
studies (Ashcroft et al 1966, Bowers et al 
1969, & Subrahmanyam 1975) have report-
ed low base line 5-HIAA values in schi-
zophrenic patients. 
An evaluation of the existing studies 
(Ashcroft et al 1966, Persson and Ross 
1969, Rimon et al 1971, Post et al 1975, 
Subramanyam 1975, Bowers 1973 and 
Bowers 1974 c) shows that the patient po-
pulation in all the studies consisted of acute 
schizophrenics or chronic schizophrenics 
or acute and chronic schizophrenics. Whe-
reas it is doubtful whether acute schizoph-
renia is actually related to schizophrenic 
syndrome or is closer to affective disorders 
(Winokur et al 1972, McCabe et al 1971), 
it is more or less proved that definite 
changes occur in pre-and post-synaptic do-
pamine receptors in chronic schizophrenics 
(Bloom 1975). Hence studies conducted on 
such a sample should be viewed with cau-
tion. Atleast in one study (Bowers et al 
1969) even the diagnosis of patients is not 
clearly mentioned. Similarly two studies 
(Ashcroft et al. 1966 and Subrahmanyam 
1975) have included even neurological pa-
tients among their control groups. In the 
study of Persson and Ross (1969) patients 
were not drug free at the time of investiga-
tion. 
Furthermore, we could not come across 
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any study which controlled relevant va-
riables like diet, drugs, motor activity, the 
spinal level of lumbar puncture and the 
amount of C. S. F. taken. We, therefore, de-
cided to conduct a study in which all these 
variables are simultaneously controlled. 
Aim 
The present study has been part of ano-
ther research project "A comprehensive 
Biopsychological Study of Functional Psy-
choses". The present paper is concerned on-
ly with finding out the ditterence in the 
rate of central turnover of dopamine and 
serotonin in schizophrenic patients and 
controls. 
Material and Methods 
A) Selection of the study population 
The population of the present study was 
drawn from the schizophrenic patients at-
tending the Walk-in-Clinic. Department of 
Psychiatry, National Institute of Mental 
Health and Neuro Sciences, Bangalore. 
The initial diagnosis of Schizophrenia was 
made according to International Classifica-
tion of Diseases - 9th version which is rou-
tinely used in our institute. However to 
avoid the diagnostic impression of ICD 9 
each patient was reevaluated diagnostically 
on a structured protorma incorporating a 
set of tour criteria. The first three criteria 
are meant to exclude the kinds of psychoses 
which according to Manfred Bleuler "are 
definitely not schizophrenic" (World 
Health Organization 1973). The fourth 
criterion was that recommended by Mark 
and Phillips (1973) for "rapid, easy and ac-
curate diagnosis of Schizophrenia in a large 
group of suspected schizophrenic cases". 
These tour criteria were 
1) Absence of significant precipitating fac-
tor at the onset ot the illness. 
2) Absence ot any evidence ot impairment 
in primary mental functions. 
3) Absence of primary involvement of 
mood. 
4) Presence of any two of the following 
a) Any of the Schneider's first rank 
symptoms. 
b) Irrelevance or incoherence 
c) Incongruity of affect 
d) A continuous illness of more than one 
year duration with absent insight. 
The fourth criteria also has the advan-
tage of incorporating both acute as well as 
chronic patients in the study population be-
cause it provides a diagnostic weightage to 
the duration of schizophrenia (more than 
one year) and at the same time, allows one 
to diagnose schizophrenia even if the dura-
tion is less than one year. 
Those patients who satisfied the 
above criteria were diagnosed as schi-
zophrenia for purpose of the study. These 
schizophrenic patients were reevaluated 
against certain exclusion criteria, viz., 
1) Non-availability of explicitly written in-
formed consent for participation in the 
study. 
2) History of intake of any drug during the 
past one month because drugs like phe-
nothiazines are known to affect the tur-
nover of central neurotransmitters 
(Creese et al. 1978). 
3) Uncooperative, excessively withdrawn, 
excited or suicidal patients. 
4) Presence of physical illness as revealed 
by detailed history, physical examina-
tion and base line haematological (Hae-
moglobin 7u, total and differential leuko-
cyte count and general blood picture) & 
urine (Albumin, sugar and microscopic) 
examinations. Wherever the presence of 
any physical illness was even remotely 
suspected, further investigations as 
deemed necessary (e.g., X-rays of various R. S. PANDEY ET AL.  205 
part of body, electrocardiogram, elec-
troencephalogram etc) were performed 
to rule out the possibility of an existing 
organic disorder. 
5) Female patients (because of certain ad-
ministrative problems, it was not pos-
sible to include female patients in the 
sample). 
The schizophrenic patients who were 
included in the study (according to the afo-
resaid inclusion and exclusion criteria) 
were further sub-categorized into various 
subtypes of schizophrenia according to In-
ternational Classification of Diseases - 9th 
version. 
B) Selection of controls 
Male patients diagnosed as cases of 
acute reaction to stress of neurotic inten-
sity (diagnosed according to ICD-9 by a 
psychiatric consultant) were taken as con-
trols for the study. These patients had not 
taken any drugs in the past one month and 
had no clinically discernable physical ill-
ness. They were treated with supportive 
psychotherapy and were included in the 
study when they had recovered comple-
tely. 
C) Preparation of the patient population 
All the subjects included (schizophren-
ic patients and controls) in the study: 
a) were admitted in the inpatient section of 
the hospital. 
b) were not given any drugs during the first 
seven days of hospitalisation. 
c) Were provided with a long list of high mo-
noamine containing dietary substances 
(e.g., banana, tea, cocoa, coffee, chocolate 
etc.,) and were forbidden to take any of 
these food stuffs during the period of stu-
dy because they are likely to increase the 
metobolites of the monoamines in the 
brain (Muscettola et al 1977). 
d) were administered various psychological 
tests including Inpatient Multidimensional 
Psychiatric Scale (Lorr et al 1963) but the 
present paper is connected mainly with 
the biochemical parameters. 
D) Collection of C.S. F. 
1. All the patients were kept on bed 
rest for 18 hours prior to lumbar puncture 
because motor activity even four hours be-
fore lumbar puncture increases 5-HIAA & 
HVA levels (Post et al 1973 a) probably be-
cause of increased metabolism and increase 
intermingling of cisternal and subarachnoid 
C. S. F. (Postetal 1973 b) but if the patients 
are kept on bed rest for 18 hours before 
lumbar puncture, the prior activity does not 
affect the amine metabolite levels (Weiss et 
al 1974). 
2. After 18 hours of rest, with aseptic 
precautions, lumbar puncture was done 
between L3 and L4 vertebrae and five ml. 
of C. S. F. was collected. The amount of 
C.S. F. collected was restricted to five ml 
only because withdrawal of larger amounts 
of C. S. F. may give falsely high values for 
H. V. A & 5 HIAA because of a high ventri-
culothecal gradient for these metabolites. 
(Moir et al 1970). The level of lumber 
puncture was kept constant in each case i.e., 
between L3 and L4 vertebrae so that the 
amine values in each case may be equally 
affected by the ventriculolumbar gradient 
for HVA and 5 HIAA. 
Thereafter, the patients were given oral 
probenecid 100 mgm/kg of body weight in 
5 divided doses at two hourly intervals to 
block the transport of HVA and 5 HIAA 
from C.S. F. to blood. We gave such high 
doses of probenecid, because at lower doses 
of probenecid the 5 HIAA and HVA levels 
correlate with C. S. F. probenecid level 
(Korf and Van Praag 1971, Sjostrom 1972, 
Bowers 1974d, Muizelaar and Oberink 
1975) but at higher doses of oral probene-
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such correlations do not exist (Perel et al 
1974). After the total dose ot probenecid 
was administered, again a lumbar puncture 
was performed between L3 and L4 verte-
brae and 5 cc ot C. S. P. was taken. 
The C. S. F. was collected into ascorbic 
acid vials which were immediately kept in 
deep freeze at -20°C. 
C.S. F. 5 Hydroxyindoleacetic acid and 
homovanillic acid were determined by 
spectro-fluorometric methods using 
Amico-Bowman Spectrofluorometer. 
Results and Discussion 
Study population 
Out of 146 schizophrenic patients 
only 20 patients satisfied all the criteria for 
inclusion in the study. While such a large 
number of rejections of patients shows the 
stringency of our criteria for selection of 
cases, it also reflects that the study popu-
lation was highly selective and not repre-
sentative of schizophrenic population at-
tending the Walk-in Clinic. Because of 
this limitation, the results derived from 
the sample cannot be freely generalised 
on the schizophrenic population in gen-
eral. The subcategories of schizophrenia 
(according to ICD-9) included in the stu-
dy population were paranoid schizophre-
nia (n = 10), catatonic schizophrenia (n=6) 
and hebephrenic schizophrenia (n=4). To 
highlight the homogeneity of the sub-
types of schizophrenia, it may be men-
tioned that a DEC-10 system computer 
using the items of Inpatient Multidimen-
sional Psychiatric Scale (Lorr et al 1963) 
isolated the three diagnostic categories 
(Paranoid, catatonic and hebephrenic 
schizophrenia) with 100% concordance 
at a similar index of 0.89 from a broader 
psychiatric sample group of 30. The num-
ber of controls was 9. The individual va-
lues of C. S. F. H. V. A. and 5HIAA are gi-
ven in Table 1. 
Analysis of C.S. F. 5 HIAA values 
As shown in table 2, the baseline (pre-
probenecid) 5 HIAA level was significantly 
higher in the controls than in the schizoph-
renic patients (p < 0.05). The post probene-
cid 5 HIAA value also was significantly hig-
her in the controls than in the schizophren-
ics (p < 0.05). However, there was no statis-
tically significant difference between accu-
mulation of 5 HIAA (difference between 
postprobenecid and baseline 5 HIAA value) 
in the two groups. 
For the purpose of statistical analysis the 
schizophrenic population was divided into 
two groups paranoid schizophrenics and 
non-paranoid schizophrenics (catatonic 
schizophrenics and hebephrenic schi-
zophrenics). As shown i~ Table 3 when 
the controls, paranoid and non-paranoid 
schizophrenics were compared, there was 
no statistically significant difference in 
baseline (preprobenecid) and probenecid 
induced 5 HIAA accumulation of the 
three groups. 
As shown in Table 2 there was no statis-
tically significant difference between the 
baseline, postprobenecid and probenecid 
induced accumulation of H. V. A. in the 
schizophrenics and the controls. 
However, as shown in Table 3 when the 
controls, paranoid schizophrenics and non-
paranoid schizophrenics were compared, 
the paranoid schizophrenics had signifi-
cantly lower baseline HVA value than 
those of the nonparanoid schizophrenics 
and the controls (p< .01). There was no sta-
tistically significant difference between the 
preprobenecid HVA and probenecid-in-
duced HVA accumulation among the three 
groups. 
Interpretation of Results 
Even though there are several reports 
against brain contribution of lumber C.S.F. 
5 HIAA (Bulat and Zivikovic 1971, Post R. S. PANDEY ET AL  207 
S.No. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
28. 
29. 
Individual values of C. S. F. 
Diagnosis 
Paranoid Schizophrenia 
-
-
-
-
-
-
-
-
-
Catatonic Schizophrenia 
" 
" 
-
-
-
Hebephrenic Schizophrenia 
-
-
-
Control 
Control 
Control 
Control 
Control 
Control 
Control 
Control 
Control 
Table 1 
5 H. I. A. A. and H. V. A. in patients 
5 H.I.A.A. 
ng/ml 
Base line Posi 
22.2 
14.0 
20.0 
24.0 
26.0 
18.0 
31.2 
24.0 
37.2 
20.6 
34.4 
13.0 
35.0 
140.0 
92.0 
94.0 
23.0 
13.0 
104.0 
83.2 
38.0 
65.0 
29.0 
60.0 
22. 
172.0 
200.0 
118.0 
78.6 
t probenecid 
31.0 
28.0 
18.0 
34.0 
28.0 
45.5 
31.0 
38.0 
20.6 
32.0 
10.0 
12.8 
20.0 
122.0 
108.4 
84.0 
24.2 
14.0 
142.0 
120.4 
60.0 
20.4 
62.0 
65.5 
101.0 
172.0 
171.0 
178.0 
188.4 
and controls 
H. V. A. 
(ng/ml) 
Base line Post probenecid 
38.0 
35.0 
15.0 
22.0 
36.0 
38.0 
32.0 
17.0 
18.0 
28.0 
42.4 
78.0 
48.0 
32.8 
38.0 
38.7 
65.0 
65.0 
37.0 
34.1 
44.0 
40.6 
74.0 
50.0 
42.0 
36.6 
32.2 
35.0 
45.0 
37.0 
28.4 
20.0 
38.0 
28.0 
48.0 
32.0 
16.0 
28.0 
30.0 
45.0 
45.0 
45.0 
28.0 
32.0 
38.0 
48.0 
50.0 
39.4 
35.4 
43.0 
48.0 
79.0 
95.0 
38.0 
32.2 
28.0 
35.0 
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Table 2 
Comparison of CSF 5 HIAA and HVA. in schizophrenics ; nd cc 
SI. 
No. 
1. 
2. 
3. 
4. 
5. 
6. 
Biochemical parameter 
studied 
Baseline CSF 5 HIAA 
Postprobenecid 
Probenecid induced accumu 
lation of 5 HIAA 
Base line CSF HVA 
Post probenecid 
C. S. F. H. V. A. 
Probenecid induced accumula 
tion of H. V. A. 
Mean (M) and 
control 
M 
SD 
M 
SD 
M 
M 
SD 
M 
SD 
M 
86.9556 
63.471 
113.1441 
64.3622 
47.1222 
44.3778 
12.3808 
48.1337 
23.1368 
3.7533 
standard  Deviation 
schizophrenics (S) 
M 
SD 
M 
SD 
M 
M 
SD 
M 
SD 
M 
43.44 
37.1309 
48.195 
41.8482 
12.785 
37.9 
16.2155 
35.56 
9.5085 
2.34 
Statistical Significance 
(using students 't' test) 
P<0.05 
Controls > schizophrenics 
P<0.05 
Controls > Schizophrenics 
No Significant difference 
p > 0.05 
No significant difference 
p >0.05 
No significant difference 
p >0.05 
No significant difference 
p>0.05 
Table 3 
Comparison of C.S. F. 5 HIAA and HVA in controls, paranoid schizophrenics and nonparanoid 
schizophrenics 
Si. Biochemical parameter 
No. studied 
Mean (M) and standard Deviation Statistical significance 
controls paranoid Non paranoid (using F test) 
schizophrenics schizophrenics 
1. 
2. 
3. 
4. 
Baseline C. S. F. 5 HIAA M 86.9556 M 23.72  M  63.16 
Post probenecid 
C.S.F. 5HIAA 
Probenecid induced 
5 HIAA accumulation 
Baseline C.S. F. HVA 
M 
SD 
113.1441 M 30.61 
64.36"22 SD 7.9089 
26.1885  6.89 
M 65.78 
SD 54.2899 
2.62 
5. Post probenecid 
C.S.F. H.V.A. 
6. Probenecid induced HVA 
accumulation 
No Significant 
difference p >0.05 
No significant 
difference p >0.05 
No significant 
difference p >0.05 
N 
SD 
M 
SD 
44.3778 
12.3808 
48.1337 
23.1368 
3.7559 
M 
SD 
M 
SD 
27.9 
9.1585 
30.54 
0.0960 
2.64 
M 
SD 
M 
SD 
47.9 
15.7797 
40.58 
7.2200 
7.32 
P < 0.01 paranoid 
< Non paranoid 
schizophrenics 
and controls 
No significant 
p>0.05 
No significant 
difference p >0.05 
et al 1973, Garelis & Sourkes 1973, Young 
etal 1973), the bulkot evidenceisinfavour 
of a major brain contribution (Eccleston et 
al 1970, Tamarkin et al 1970, Curzon et al 
1971, Sourkes 1973, Garelis and Sourkes 
1973 and Aghajanian & Gallager 1975). 
Likewise, some HVA release occurs 
from the cord alsol(Kessler et al 1976, and 
Bingham et al, 1975), but there is enough li-
terature to suggest substantial brain contri-
bution (Garelis & Sourkes 1973, Curzon et 
al 1971, Post et al 1973, Tamkarkin et al 
1970). 
From these evidences it can reasonably 
be inferred that lumbar C.S.F. 5 HIAA and 
HVA levels reflect cerebral serotonin and 
dopamine turnover respectively. Combin-
ing these facts, it can be inferred that: R. S. PANDEY ET AL  209 
1. The schizophrenics have lower cen-
tral serotonin turnover than the con-
trols (P < 0.001). 
2. There is no statistically significant dif-
ference between the central serotonin 
turnover of the paranoid and non-pa-
ranoid schizophrenics. 
3. There is no statistically significant dif-
ference between the central dopamine 
turnover of the control and the schi-
zophrenic patients. 
4. There is no statistically significant dif-
ference between the central dopamine 
turnover in controls, paranoid schi-
zophrenics and non-paranoid schi-
zophrenics. 
5. Since probenecid induced HVA accu-
mulation in paranoid schizophrenics is 
not significantly different from that of 
controls and non-paranoid schizoph-
renics but there is a statistically signi-
ficant (P < 0.01) lower baseline HVA 
value in paranoid schizophrenics than 
in the controls or non-paranoid schi-
zophrenics, it can be inferred that the 
active transport process responsible 
for extrusion of HVA from C.S.F. to 
blood is more active in paranoid schi-
zophrenics than in controls or non-pa-
ranoid schizophrenics because the ac-
tion of probenecid is merely to block 
the active transport of acid amine me-
tabolites from C.S.F. to blood (Weiss 
et al 1974). However in view of the 
very small number of patients in this 
study such an inference should await 
further confirmation till similar stu-
dies conducted on larger patient popu-
lation furnish similar results. 
It is well known that certain hallucinog-
ens like L.S.D. 25 have marked anti-seroto-
nin action and this had at one time led to 
the hypothesis that schizophrenia occurs 
because of decreased cerebral serotonin ac-
tivity (Woolley and Shaw 1954). The na-
ture of hallucinations (auditory or visual) 
was however never mentioned. The hypo-
thesis was later on rejected in favour of do-
pamine hypothesis of schizophrenia (Mat-
thyssee and Sugarman 1978). In addition, 
the post mortem examination of schizoph-
renic brains did not show serotoninergic 
deficiency (Crow et al. 1979). However, 
from the results of International Pilot Study 
of Schizophrenia, it is well established that 
among all symptoms of schizophrenia, au-
ditory hallucinations are the most valuable 
ones because they have high specificity 
(discriminatory power), high frequency 
(74 %) and also a high reliability of 0.86 
(Lehmann 1976). Taking into considera-
tion the importance of auditory hallucina-
tions in schizophrenia the fact that de-
creased serotonin activity can probably pro-
duce hallucinations and our observation 
that the brain serotonin turnover is signifi-
cantly less in schizophrenics than in con-
trols, we hypothesize that while decreased 
brain serotonin activity may not be of aetio-
logical significance in schizophrenia, it may 
possibly be a symptom formation factor in 
schizophrenia as far as hallucinations are 
concerned. 
Eighteen of the twenty schizophrenic 
patients in our study had one or more types 
of auditory hallucinations (commenting 
voices, 3rd person auditory hallucinations 
or thought echo) and therefore, a statistical 
comparison of the C.S.F. 5 HIAA levels of 
patients with and without auditory halluci-
nations is not possible. A separate study 
which specifically compares the C.SF. 5 
HIAA levels in schizophrenic patients with 
or without hallucinations, may resolve the 
issue. 
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